INS and pancreatic insulinoma: In addition, risk assessment is also done based on the presence of plasma autoreactive antibodies (autoantibodies) against β-cell antigens such as, pro-insulin and insulin, glutamic acid decarboxylase (GAD), tyrosine phosphatase present in insulinomas (anti-IA2), and Zinc transporter 8 (ZnT8).